It is a transport and logistics private limited company based in Delhi, Delhi, India, established in 1997.
1997 | Delhi, Delhi, India | ActiveArpit Pharmaceuticals Private Limited, a active private limited company, was established on 01 April 1997 in Delhi, Delhi, India. Engaging in carrying & forwarding agents (cfa) within the trade sector, it holds CIN: U24232DL1997PTC086333. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.50 M and a paid-up capital of ₹2.90 M.
It upholds a compliant status. Its leadership includes Arvind Kumar (Director), Anita Kumari (Director), Anshul Karnwal (Director). It holds no open charges and ₹1.70 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 5, Manak Vihar Opposite Yojna Vihar,, Delhi, Delhi, 110092.
U24232DL1997PTC086333
086333
01 April 1997
₹3.50 M
₹2.90 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Arpit Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arvind Kumar | Director | 01 Apr 1997 | Current |
| Anita Kumari | Director | 01 Apr 1997 | Current |
| Anshul Karnwal | Director | 06 Feb 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Arpit Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1039.61% increase. The company also saw a substantial improvement in profitability, with a 310.25% increase in profit. The company's net worth dipped by a decrease of 0.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Arpit Pharmaceuticals had a promoter holding of 21.86% and a public holding of 78.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹16,968,598.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2021 | Hdfc Bank Limited | ₹1.44 M | Satisfied |
| 23 Jun 2007 | Hdfc Bank Limited | ₹1.25 Cr | Satisfied |
| 30 Mar 2006 | Citibank N.A. | ₹3.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Arpit Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Arpit Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arpit Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Anshul Karnwal was appointed as a Director was appointed as a Director on 06 Feb 2025 & has been associated with this company since 9 months 26 days . was completed.
Progress on Arpit Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity A charge registered on 30 Jul 2021 via Charge ID 100479649 with Hdfc Bank Limited was fully satisfied on 11 Sep 2024. was completed.
Progress on Arpit Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 1.44 M with Charge ID 100479649 was registered on 30 Jul 2021. was completed.
The activity A charge registered on 23 Jun 2007 via Charge ID 10095798 with Hdfc Bank Limited was fully satisfied on 26 May 2014. was completed.
The CIN of Arpit Pharmaceuticals Private Limited is U24232DL1997PTC086333.
Arpit Pharmaceuticals Private Limited is headquartered at 5, Manak Vihar Opposite Yojna Vihar,, Delhi, Delhi, 110092.
Arpit Pharmaceuticals Private Limited was incorporated on 01 April 1997.
The current directors of Arpit Pharmaceuticals Private Limited are
The primary industry of Arpit Pharmaceuticals Private Limited is Trade.
Arpit Pharmaceuticals Private Limited is unlisted.
The authorized capital of Arpit Pharmaceuticals Private Limited is ₹3.50 M, and the paid-up capital is ₹2.90 M.
The compliance status of Arpit Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX